To date, we have contributed to the development of medical care and life sciences research through the generation of antibody drugs and reagents for cancer research. To further support our customers through our technologies and experience, we have launched new antibody research support and contract services on December 1, 2018. In addition to the services listed on our menu, we offer other services to meet our customers' needs and demands. Please feel free to contact us for more information.